Jiangsu Coben Pharmaceutical Co., Ltd.

About Jiangsu Coben Pharmaceutical Co., Ltd.

Founded in 2005, Coben Group was designed and built according to GMP standard with a total area of 100,000㎡, a member of ZJMI Group-Global Fortune 500, Ranked No.270 in 2018.
Coben is specialized in developing and manufacturing of APIs and intermediates for various drugs. Main products include: Sofosbuvir, Tenofovir, Ticagrelor, Sacubitril, Voriconazole, Isavuconazole and their intermediates.

Certifications
  • Country/Region:
    China
  • On CPHI since:
    2018
  • Certificates:
    2
  • Employees:
    250 - 499
Company types
Pharmaceutical company
Primary activities
API Producer
Intermediates Manufacturer
Contact info
Meet us at

CPHI & PMEC China 2026

Shanghai New International Expo Center
16 Jun 2026 - 18 Jun 2026

Products from Jiangsu Coben Pharmaceutical Co., Ltd. (10)

Jiangsu Coben Pharmaceutical Co., Ltd. Resources (1)